Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death

作者: Joseph J Lynch , Lawrence A Coskey , Daniel G Montgomery , Benedict R Lucchesi

DOI: 10.1016/0002-8703(85)90234-0

关键词:

摘要: The antiarrhythmic and antifibrillatory actions of the dextrorotatory isomer sotalol, administered in a multiple-dose regimen, were evaluated conscious dogs 3 to 5 days after anterior myocardial infarction. intravenous administration d-sotalol, four 8 mg/kg doses over 24-hour treatment period, suppressed induction ventricular tachycardia by programmed electrical stimulation six nine tested, slowed rate induced tachyarrhythmia two remaining three dogs, provided significant protection (5 d-sotalol vs 0 vehicle control) against development fibrillation response ischemia at site distant previous Increases refractoriness QTc paced QT intervals suggest that class III electrophysiologic contribute properties sotalol this animal model. degree beta-adrenergic receptor blockade produced dose regimen was negligible. These findings potential utility prevention setting infarction, particularly when is undesirable or contraindicated.

参考文章(32)
Eugene Patterson, Kurt Holland, Brian T. Eller, Benedict R. Lucchesi, Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. American Journal of Cardiology. ,vol. 50, pp. 1414- 1423 ,(1982) , 10.1016/0002-9149(82)90484-2
P. M. Lish, J. H. Weikel, K. W. Dungan, Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. Journal of Pharmacology and Experimental Therapeutics. ,vol. 149, pp. 161- 173 ,(1965)
B R Lucchesi, J J Lynch, E Patterson, Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol. Journal of Pharmacology and Experimental Therapeutics. ,vol. 230, pp. 519- 526 ,(1984)
Fred Morady, Melvin M. Scheinman, David S. Hess, Ruey J. Sung, Edward Shen, William Shapiro, Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest The American Journal of Cardiology. ,vol. 51, pp. 85- 89 ,(1983) , 10.1016/S0002-9149(83)80016-2
D H Bennett, Acute prolongation of myocardial refractoriness by sotalol. Heart. ,vol. 47, pp. 521- 526 ,(1982) , 10.1136/HRT.47.6.521
Jean Torresani, Bretylium tosylate in patients with acute myocardial infarction The American Journal of Cardiology. ,vol. 54, pp. A20- A25 ,(1984) , 10.1016/0002-9149(84)90813-0
A W Nathan, K J Hellestrand, R S Bexton, D E Ward, R A Spurrell, A J Camm, Electrophysiological effects of sotalol--just another beta blocker? Heart. ,vol. 47, pp. 515- 520 ,(1982) , 10.1136/HRT.47.6.515
David J. Wilber, Joseph J. Lynch, Daniel Montgomery, Benedict R. Lucchesi, Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. American Heart Journal. ,vol. 109, pp. 8- 18 ,(1985) , 10.1016/0002-8703(85)90409-0
Lon Castle, Therapy of ventricular tachycardia The American Journal of Cardiology. ,vol. 54, pp. A26- A33 ,(1984) , 10.1016/0002-9149(84)90814-2
Brian McGovern, Hasan Garan, Robert F. Malacoff, John P. Dimarco, Gail Grant, T.Duncan Sellers, Jeremy N. Ruskin, Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone The American Journal of Cardiology. ,vol. 53, pp. 1558- 1563 ,(1984) , 10.1016/0002-9149(84)90579-4